These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32843530)

  • 1. Evaluation of High-Throughput Serological Tests for SARS-CoV-2.
    Loeffelholz MJ
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32843530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of SARS-CoV-2 IgG Targeting Nucleocapsid or Spike Protein by Four High-Throughput Immunoassays Authorized for Emergency Use.
    Prince HE; Givens TS; Lapé-Nixon M; Clarke NJ; Schwab DA; Batterman HJ; Jones RS; Meyer WA; Kapoor H; Rowland CM; Haji-Sheikhi F; Marlowe EM
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32817144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation.
    Jääskeläinen AJ; Kuivanen S; Kekäläinen E; Ahava MJ; Loginov R; Kallio-Kokko H; Vapalahti O; Jarva H; Kurkela S; Lappalainen M
    J Clin Virol; 2020 Aug; 129():104512. PubMed ID: 32563180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of ELISA method with three other automated serological tests for the detection of anti-SARS-CoV-2 antibodies.
    Nguyen NN; Mutnal MB; Gomez RR; Pham HN; Nguyen LT; Koss W; Rao A; Arroliga AC; Wang L; Wang D; Hua Y; Powell PR; Chen L; McCormack CC; Linz WJ; Mohammad AA
    PLoS One; 2020; 15(10):e0240076. PubMed ID: 33022019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.
    Meschi S; Colavita F; Bordi L; Matusali G; Lapa D; Amendola A; Vairo F; Ippolito G; Capobianchi MR; Castilletti C;
    J Clin Virol; 2020 Aug; 129():104539. PubMed ID: 32679298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs.
    Van Elslande J; Decru B; Jonckheere S; Van Wijngaerden E; Houben E; Vandecandelaere P; Indevuyst C; Depypere M; Desmet S; André E; Van Ranst M; Lagrou K; Vermeersch P
    Clin Microbiol Infect; 2020 Nov; 26(11):1557.e1-1557.e7. PubMed ID: 32745595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2.
    Theel ES; Harring J; Hilgart H; Granger D
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32513859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological differentiation between COVID-19 and SARS infections.
    Chia WN; Tan CW; Foo R; Kang AEZ; Peng Y; Sivalingam V; Tiu C; Ong XM; Zhu F; Young BE; Chen MI; Tan YJ; Lye DC; Anderson DE; Wang LF
    Emerg Microbes Infect; 2020 Dec; 9(1):1497-1505. PubMed ID: 32529906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
    Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
    J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays.
    DomBourian MG; Annen K; Huey L; Andersen G; Merkel PA; Jung S; Dominguez SR; Knight V
    J Immunol Methods; 2020 Nov; 486():112837. PubMed ID: 32828791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach.
    van Tol S; Mögling R; Li W; Godeke GJ; Swart A; Bergmans B; Brandenburg A; Kremer K; Murk JL; van Beek J; Wintermans B; Reimerink J; Bosch BJ; Reusken C
    Emerg Microbes Infect; 2020 Dec; 9(1):1965-1973. PubMed ID: 32819220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data.
    Naaber P; Hunt K; Pesukova J; Haljasmägi L; Rumm P; Peterson P; Hololejenko J; Eero I; Jõgi P; Toompere K; Sepp E
    PLoS One; 2020; 15(10):e0237548. PubMed ID: 33108380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
    Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
    Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
    Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Validation and Performance Evaluation of the Automated Vitros Total Anti-SARS-CoV-2 Antibodies Assay for Screening of Serostatus in COVID-19.
    Garnett E; Jung J; Tam E; Rajapakshe D; Cheney S; Brown C; Cao J; Muldrew K; Singh I; Versalovic J; Devaraj S
    Am J Clin Pathol; 2020 Nov; 154(6):742-747. PubMed ID: 32864699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays.
    Kohmer N; Westhaus S; Rühl C; Ciesek S; Rabenau HF
    J Clin Virol; 2020 Aug; 129():104480. PubMed ID: 32505777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2.
    Johnson M; Wagstaffe HR; Gilmour KC; Mai AL; Lewis J; Hunt A; Sirr J; Bengt C; Grandjean L; Goldblatt D
    J Clin Virol; 2020 Sep; 130():104572. PubMed ID: 32769024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies.
    Beavis KG; Matushek SM; Abeleda APF; Bethel C; Hunt C; Gillen S; Moran A; Tesic V
    J Clin Virol; 2020 Aug; 129():104468. PubMed ID: 32485620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.